Increased levels of 18-HEPE, secondary to EPA-supplementation or in fat-1-transgenic mice that convert ω6- to ω3-PUFAs, are associated with prevention of atherosclerosis and pathologic ventricular remodeling post-TAC (62, 63). Here, FAT1 is linked to atherosclerosis.